Northeastern University School of Pharmacy, 206 Mugar Life Sciences Building, Boston, MA 02115-5000, USA.
J Subst Abuse Treat. 2010 Apr;38(3):292-8. doi: 10.1016/j.jsat.2010.01.005. Epub 2010 Feb 4.
Studies demonstrate associations between nonmedical use of prescription stimulants (NMUPS) and depressed mood; however, relevance of NMUPS route of administration and frequency of use have not been examined. We hypothesized frequent NMUPS and nonoral routes would be significantly associated with depressed mood. A Web survey was self-administered by a probability sample of 3,639 undergraduate students at a large U.S. university. The survey contained substance use (e.g., frequency, route of administration) and depressed mood measurement. Past-year prevalence of NMUPS was 6.0% (n = 212). Approximately 50% of frequent or nonoral NMUPS reported depressed mood. Adjusted odds of depressed mood were over two times greater among frequent monthly NMUPS (adjusted odds ratio [AOR] = 2.3, 95% confidence interval [CI] = 1.01-5.15) and nonoral routes of administration (AOR = 2.2, 95% CI = 1.36-3.70), after controlling for other variables. Nonmedical users of prescription stimulants should be screened for depressed mood, especially those who report frequent and nonoral routes of administration.
研究表明,非医疗用途处方兴奋剂(NMUPS)的使用与情绪低落之间存在关联;然而,尚未研究 NMUPS 的给药途径和使用频率的相关性。我们假设,频繁使用 NMUPS 和非口服途径与情绪低落显著相关。一项网络调查由美国一所大型大学的概率样本 3639 名本科生自行管理。该调查包含药物使用(例如,使用频率、给药途径)和情绪低落的测量。过去一年 NMUPS 的流行率为 6.0%(n = 212)。大约 50%的频繁或非口服 NMUPS 报告情绪低落。在控制其他变量后,频繁每月 NMUPS(调整后的优势比[OR] = 2.3,95%置信区间[CI] = 1.01-5.15)和非口服给药途径(调整后的 OR = 2.2,95%CI = 1.36-3.70)的情绪低落的调整后优势比更高。应筛查处方兴奋剂的非医疗使用者是否存在情绪低落问题,尤其是那些报告频繁使用和非口服途径的使用者。